Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 307 articles:
HTML format

Single Articles

    January 2021
  1. PEDRONI C, Dujeu M, Lebacq T, Desnouck V, et al
    Alcohol consumption in early adolescence: Associations with sociodemographic and psychosocial factors according to gender.
    PLoS One. 2021;16:e0245597.
    PubMed     Abstract available

  2. ESTRADA-MARTINEZ S, Perez-Alamos AR, Ibarra-Segovia M, Beristain-Garcia I, et al
    Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.
    PLoS One. 2021;16:e0245701.
    PubMed     Abstract available

  3. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available

  4. Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2021;16:e0247690.
    PubMed     Abstract available

  5. HENNEIN R, Mew EJ, Lowe SR
    Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
    PLoS One. 2021;16:e0246602.
    PubMed     Abstract available

  6. DARLING KEA, Locatelli I, Benghalem N, Nadin I, et al
    Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    PLoS One. 2021;16:e0246579.
    PubMed     Abstract available

  7. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    PubMed     Abstract available

  8. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    PubMed     Abstract available

  9. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    PubMed     Abstract available

  10. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    PubMed     Abstract available

  11. BAE CR, Zhang H, Kwon YG
    Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2021;16:e0249747.
    PubMed     Abstract available

  12. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    PubMed     Abstract available

  13. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    PubMed     Abstract available

  14. CONGLY SE, Shaheen AA, Swain MG
    Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
    PLoS One. 2021;16:e0251741.
    PubMed     Abstract available

  15. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed     Abstract available

  16. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    PubMed     Abstract available

  17. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    PubMed     Abstract available

  18. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
    The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
    PLoS One. 2021;16:e0252441.
    PubMed     Abstract available

  19. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    PubMed     Abstract available

  20. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    PubMed     Abstract available

  21. PRO G, Gilbert PA, Baldwin JA, Brown CC, et al
    Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US.
    PLoS One. 2021;16:e0253466.
    PubMed     Abstract available

    January 2020
  22. MELBY K, Fasmer OB, Henriksen TE, Grawe RW, et al
    Actigraphy assessment of motor activity and sleep in patients with alcohol withdrawal syndrome and the effects of intranasal oxytocin.
    PLoS One. 2020;15:e0228700.
    PubMed     Abstract available

  23. WAN YM, Li ZQ, Liu C, He YF, et al
    Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress.
    PLoS One. 2020;15:e0228889.
    PubMed     Abstract available

  24. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    PubMed     Abstract available

  25. HTET H, Saw YM, Saw TN, Htun NMM, et al
    Prevalence of alcohol consumption and its risk factors among university students: A cross-sectional study across six universities in Myanmar.
    PLoS One. 2020;15:e0229329.
    PubMed     Abstract available

  26. LEMOINE M, Gmel G, Foster S, Marmet S, et al
    Multiple trajectories of alcohol use and the development of alcohol use disorder: Do Swiss men mature-out of problematic alcohol use during emerging adulthood?
    PLoS One. 2020;15:e0220232.
    PubMed     Abstract available

  27. LUBMAN DI, Matthews S, Heilbronn C, Killian JJ, et al
    The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records.
    PLoS One. 2020;15:e0228316.
    PubMed     Abstract available

  28. KOVACS I, Demeter I, Janka Z, Demetrovics Z, et al
    Different aspects of impulsivity in chronic alcohol use disorder with and without comorbid problem gambling.
    PLoS One. 2020;15:e0227645.
    PubMed     Abstract available

  29. NING K, Gondek D, Patalay P, Ploubidis GB, et al
    The association between early life mental health and alcohol use behaviours in adulthood: A systematic review.
    PLoS One. 2020;15:e0228667.
    PubMed     Abstract available

  30. MEKONEN HH, Birhanu MM, Mossie TB, Gebreslassie HT, et al
    Factors associated with stroke among adult patients with hypertension in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia, 2018: A case-control study.
    PLoS One. 2020;15:e0228650.
    PubMed     Abstract available

  31. MAGWOOD O, Salvalaggio G, Beder M, Kendall C, et al
    The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.
    PLoS One. 2020;15:e0227298.
    PubMed     Abstract available

  32. WOO YS, Yoon BH, Song JH, Seo JS, et al
    Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study.
    PLoS One. 2020;15:e0227217.
    PubMed     Abstract available

  33. LIN TC, Chien WC, Hu JM, Tzeng NS, et al
    Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study.
    PLoS One. 2020;15:e0232740.
    PubMed     Abstract available

  34. FEDE SJ, Abrahao KP, Cortes CR, Grodin EN, et al
    Alcohol effects on globus pallidus connectivity: Role of impulsivity and binge drinking.
    PLoS One. 2020;15:e0224906.
    PubMed     Abstract available

  35. YITAYIH Y, Soboka M, Tesfaye E, Abera M, et al
    A cross-sectional study of psychopathy and khat abuse among prisoners in the correctional institution in Jimma, Ethiopia.
    PLoS One. 2020;15:e0227405.
    PubMed     Abstract available

  36. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    PubMed     Abstract available

  37. HUGHES TL, Veldhuis CB, Drabble LA, Wilsnack SC, et al
    Research on alcohol and other drug (AOD) use among sexual minority women: A global scoping review.
    PLoS One. 2020;15:e0229869.
    PubMed     Abstract available

  38. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    PubMed     Abstract available

  39. AGUIRRE CG, Stolyarova A, Das K, Kolli S, et al
    Sex-dependent effects of chronic intermittent voluntary alcohol consumption on attentional, not motivational, measures during probabilistic learning and reversal.
    PLoS One. 2020;15:e0234729.
    PubMed     Abstract available

  40. GLASNER S, Chokron Garneau H, Ang A, Ray L, et al
    Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial.
    PLoS One. 2020;15:e0229557.
    PubMed     Abstract available

  41. GONZALES P, Grieco A, White E, Ding R, et al
    Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy.
    PLoS One. 2020;15:e0228433.
    PubMed     Abstract available

  42. ALDRIDGE LR, Garman EC, Luitel NP, Jordans MJD, et al
    Impact of a district mental health care plan on suicidality among patients with depression and alcohol use disorder in Nepal.
    PLoS One. 2020;15:e0231158.
    PubMed     Abstract available

  43. FLENTJE A, Barger BT, Capriotti MR, Lubensky ME, et al
    Screening gender minority people for harmful alcohol use.
    PLoS One. 2020;15:e0231022.
    PubMed     Abstract available

  44. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    PubMed     Abstract available

  45. HEINSCH M, Sampson D, Huens V, Handley T, et al
    Understanding ambivalence in help-seeking for suicidal people with comorbid depression and alcohol misuse.
    PLoS One. 2020;15:e0231647.
    PubMed     Abstract available

  46. GRAZIANI R, Venturini S
    A Bayesian approach to discrete multiple outcome network meta-analysis.
    PLoS One. 2020;15:e0231876.
    PubMed     Abstract available

  47. FAINI D, Hanson C, Baisley K, Kapiga S, et al
    Sexual behaviour, changes in sexual behaviour and associated factors among women at high risk of HIV participating in feasibility studies for prevention trials in Tanzania.
    PLoS One. 2020;15:e0231766.
    PubMed     Abstract available

  48. SMITH ML, Lopez MF, Wolen AR, Becker HC, et al
    Brain regional gene expression network analysis identifies unique interactions between chronic ethanol exposure and consumption.
    PLoS One. 2020;15:e0233319.
    PubMed     Abstract available

  49. GHANDOUR LA, Anouti S, Afifi RA
    The impact of DSM classification changes on the prevalence of alcohol use disorder and 'diagnostic orphans' in Lebanese college youth: Implications for epidemiological research, health practice, and policy.
    PLoS One. 2020;15:e0233657.
    PubMed     Abstract available

  50. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    PubMed     Abstract available

  51. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    PubMed     Abstract available

  52. BAIK I, Park SI
    Associations of alcohol consumption and physical activity with lean type 2 diabetes mellitus among Korean adults: A prospective cohort study.
    PLoS One. 2020;15:e0238641.
    PubMed     Abstract available

  53. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    PubMed     Abstract available

  54. FUKUSHIMA S, Kuga H, Oribe N, Mutou T, et al
    Behavioural cue reactivity to alcohol-related and non-alcohol-related stimuli among individuals with alcohol use disorder: An fMRI study with a visual task.
    PLoS One. 2020;15:e0229187.
    PubMed     Abstract available

  55. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    PubMed     Abstract available

  56. FRAZAO DR, Maia CDSF, Chemelo VDS, Monteiro D, et al
    Ethanol binge drinking exposure affects alveolar bone quality and aggravates bone loss in experimentally-induced periodontitis.
    PLoS One. 2020;15:e0236161.
    PubMed     Abstract available

  57. SAWYER KS, Adra N, Salz DM, Kemppainen MI, et al
    Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder.
    PLoS One. 2020;15:e0236641.
    PubMed     Abstract available

  58. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    PubMed     Abstract available

  59. CHEN F, Xiao M, Chen C, Chen C, et al
    Discrimination of alcohol dependence based on the convolutional neural network.
    PLoS One. 2020;15:e0241268.
    PubMed     Abstract available

  60. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    PubMed     Abstract available

  61. HENNEIN R, Lowe S
    A hybrid inductive-abductive analysis of health workers' experiences and wellbeing during the COVID-19 pandemic in the United States.
    PLoS One. 2020;15:e0240646.
    PubMed     Abstract available

  62. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    PubMed     Abstract available

  63. ADRAWA N, Alege JB, Izudi J
    Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
    PLoS One. 2020;15:e0242801.
    PubMed     Abstract available

  64. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    PubMed     Abstract available

  65. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available

  66. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    PubMed     Abstract available

  67. VORNHOLT E, Drake J, Mamdani M, McMichael G, et al
    Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.
    PLoS One. 2020;15:e0243857.
    PubMed     Abstract available

  68. RADCLIFFE RA, Dowell R, Odell AT, Richmond PA, et al
    Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance.
    PLoS One. 2020;15:e0240253.
    PubMed     Abstract available

  69. FRANK K, Abeynaike S, Nikzad R, Patel RR, et al
    Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice.
    PLoS One. 2020;15:e0239246.
    PubMed     Abstract available

  70. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available

  71. KILIAN C, Manthey J, Moskalewicz J, Scafato E, et al
    Comparing subjective intoxication with risky single-occasion drinking in a European sample.
    PLoS One. 2020;15:e0241433.
    PubMed     Abstract available

  72. LONG JE, Richardson BA, Wanje G, Wilson KS, et al
    Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    PLoS One. 2020;15:e0242817.
    PubMed     Abstract available

  73. TAVANASEFAT H, Li F, Koyano K, Gourtani BK, et al
    Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation.
    PLoS One. 2020;15:e0242276.
    PubMed     Abstract available

  74. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available

  75. SEGHER K, Huys L, Desmet T, Steen E, et al
    Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
    PLoS One. 2020;15:e0243222.
    PubMed     Abstract available

  76. BITEW MS, Zewde MF, Wubetu M, Alemu AA, et al
    Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors.
    PLoS One. 2020;15:e0243784.
    PubMed     Abstract available

  77. IGLESIAS K, Lannoy S, Sporkert F, Daeppen JB, et al
    Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men.
    PLoS One. 2020;15:e0244336.
    PubMed     Abstract available

    January 2019
  78. YOKOYAMA A, Yokoyama T, Omori T, Maesato H, et al
    Endoscopic screening using esophageal iodine staining and genotypes of ADH1B and ALDH2 in Japanese alcohol-dependent women.
    PLoS One. 2019;14:e0210546.
    PubMed     Abstract available

  79. SONG JU, Jang Y, Lim SY, Ryu S, et al
    Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.
    PLoS One. 2019;14:e0208736.
    PubMed     Abstract available

  80. ISHIKAWA T, Yokoyama H, Matsuura T, Fujiwara Y, et al
    Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease.
    PLoS One. 2019;14:e0211543.
    PubMed     Abstract available

  81. OHASHI T, Nakade Y, Ibusuki M, Kitano R, et al
    Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    PLoS One. 2019;14:e0210068.
    PubMed     Abstract available

  82. APPLEBY RN, Moghul I, Khan S, Yee M, et al
    Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    PLoS One. 2019;14:e0211348.
    PubMed     Abstract available

  83. CHOUNG S, Kim JM, Joung KH, Lee ES, et al
    Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
    PLoS One. 2019;14:e0210828.
    PubMed     Abstract available

  84. Correction: Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLoS One. 2019;14:e0212144.
    PubMed     Abstract available

  85. BEARD E, Brown J, West R, Kaner E, et al
    Associations between socio-economic factors and alcohol consumption: A population survey of adults in England.
    PLoS One. 2019;14:e0209442.
    PubMed     Abstract available

  86. LI C, Moore SC, Smith J, Bauermeister S, et al
    The costs of negative affect attributable to alcohol consumption in later life: A within-between random longitudinal econometric model using UK Biobank.
    PLoS One. 2019;14:e0211357.
    PubMed     Abstract available

  87. HERATH RP, Siriwardana SR, Ekanayake CD, Abeysekara V, et al
    Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.
    PLoS One. 2019;14:e0215326.
    PubMed     Abstract available

  88. BARMANO N, Charitakis E, Kronstrand R, Walfridsson U, et al
    The association between alcohol consumption, cardiac biomarkers, left atrial size and re-ablation in patients with atrial fibrillation referred for catheter ablation.
    PLoS One. 2019;14:e0215121.
    PubMed     Abstract available

  89. TEVIK K, Selbaek G, Engedal K, Seim A, et al
    Mortality in older adults with frequent alcohol consumption and use of drugs with addiction potential - The Nord Trondelag Health Study 2006-2008 (HUNT3), Norway, a population-based study.
    PLoS One. 2019;14:e0214813.
    PubMed     Abstract available

  90. MIGNOGNA KM, Bacanu SA, Riley BP, Wolen AR, et al
    Cross-species alcohol dependence-associated gene networks: Co-analysis of mouse brain gene expression and human genome-wide association data.
    PLoS One. 2019;14:e0202063.
    PubMed     Abstract available

  91. BEARD E, Brown J, West R, Kaner E, et al
    Correction: Associations between socio-economic factors and alcohol consumption: A population survey of adults in England.
    PLoS One. 2019;14:e0216378.
    PubMed     Abstract available

  92. DEVILLY GJ, Hides L, Kavanagh DJ
    A big night out getting bigger: Alcohol consumption, arrests and crowd numbers, before and after legislative change.
    PLoS One. 2019;14:e0218161.
    PubMed     Abstract available

  93. SALIC K, Kleemann R, Wilkins-Port C, McNulty J, et al
    Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.
    PLoS One. 2019;14:e0218459.
    PubMed     Abstract available

  94. MOLINET J, Cubillos FA, Salinas F, Liti G, et al
    Genetic variants of TORC1 signaling pathway affect nitrogen consumption in Saccharomyces cerevisiae during alcoholic fermentation.
    PLoS One. 2019;14:e0220515.
    PubMed     Abstract available

  95. LIU Y, Liu X, Wang Y, Yi C, et al
    Protective effect of lactobacillus plantarum on alcoholic liver injury and regulating of keap-Nrf2-ARE signaling pathway in zebrafish larvae.
    PLoS One. 2019;14:e0222339.
    PubMed     Abstract available

  96. HIGARZA SG, Arboleya S, Gueimonde M, Gomez-Lazaro E, et al
    Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits.
    PLoS One. 2019;14:e0223019.
    PubMed     Abstract available

  97. NAVARRO VJ, Belle SH, D'Amato M, Adfhal N, et al
    Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0221683.
    PubMed     Abstract available

  98. TANNOUS J, Mwangi B, Hasan KM, Narayana PA, et al
    Measures of possible allostatic load in comorbid cocaine and alcohol use disorder: Brain white matter integrity, telomere length, and anti-saccade performance.
    PLoS One. 2019;14:e0199729.
    PubMed     Abstract available

  99. HAGSTROM H, Widman L, von Seth E
    Association between temperature, sunlight hours and alcohol consumption.
    PLoS One. 2019;14:e0223312.
    PubMed     Abstract available

  100. TANAREE A, Assanangkornchai S, Isaranuwatchai W, Thavorn K, et al
    Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis.
    PLoS One. 2019;14:e0209210.
    PubMed     Abstract available

  101. NAVARRO VJ, Belle SH, D'Amato M, Afdhal N, et al
    Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0223915.
    PubMed     Abstract available

  102. MARTINELLI JL, Germano CMR, de Avo LRDS, Fontanella BJB, et al
    Motivation for alcohol consumption or abstinence during pregnancy: A clinical-qualitative study in Brazil.
    PLoS One. 2019;14:e0223351.
    PubMed     Abstract available

  103. NIRIELLA MA, Kasturiratna A, Beddage T, Ediriweera DS, et al
    Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    PLoS One. 2019;14:e0224474.
    PubMed     Abstract available

  104. MADDEN M, Morris S, Stewart D, Atkin K, et al
    Conceptualising alcohol consumption in relation to long-term health conditions: Exploring risk in interviewee accounts of drinking and taking medications.
    PLoS One. 2019;14:e0224706.
    PubMed     Abstract available

  105. MINAMI Y, Kanemura S, Kawai M, Nishino Y, et al
    Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study.
    PLoS One. 2019;14:e0224797.
    PubMed     Abstract available

  106. ERHARTOVA D, Cahova M, Dankova H, Heczkova M, et al
    Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    PLoS One. 2019;14:e0224820.
    PubMed     Abstract available

  107. LEE YJ, Shu MS, Kim JY, Kim YH, et al
    Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
    PLoS One. 2019;14:e0211415.
    PubMed     Abstract available

  108. XIONG X, Yu J, Fan R, Zhang C, et al
    NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
    PLoS One. 2019;14:e0212523.
    PubMed     Abstract available

  109. STADLBAUER V, Horvath A, Komarova I, Schmerboeck B, et al
    A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers.
    PLoS One. 2019;14:e0211703.
    PubMed     Abstract available

  110. AL WAHAIBI N, Al Lawati A, Al Ruqeishy F, Al Khatri A, et al
    The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation.
    PLoS One. 2019;14:e0210532.
    PubMed     Abstract available

  111. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    PubMed     Abstract available

  112. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    PubMed     Abstract available

  113. PHAM TT, Park B
    Alcohol use disorder and health-related quality of life in Korean night-shift workers: A cross-sectional study using the KNHANES 2007-2015 data.
    PLoS One. 2019;14:e0214593.
    PubMed     Abstract available

  114. GARCIA-MARCHENA N, Barrera M, Mestre-Pinto JI, Araos P, et al
    Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
    PLoS One. 2019;14:e0213791.
    PubMed     Abstract available

  115. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    PubMed     Abstract available

  116. SIEGFRIED N, Parry C
    Do alcohol control policies work? An umbrella review and quality assessment of systematic reviews of alcohol control interventions (2006 - 2017).
    PLoS One. 2019;14:e0214865.
    PubMed     Abstract available

  117. CASTANEDA SF, Garcia ML, Lopez-Gurrola M, Stoutenberg M, et al
    Alcohol use, acculturation and socioeconomic status among Hispanic/Latino men and women: The Hispanic Community Health Study/Study of Latinos.
    PLoS One. 2019;14:e0214906.
    PubMed     Abstract available

  118. FEIGL AB, Goryakin Y, Devaux M, Lerouge A, et al
    The short-term effect of BMI, alcohol use, and related chronic conditions on labour market outcomes: A time-lag panel analysis utilizing European SHARE dataset.
    PLoS One. 2019;14:e0211940.
    PubMed     Abstract available

  119. SILEO KM, Kizito W, Wanyenze RK, Chemusto H, et al
    Substance use and its effect on antiretroviral treatment adherence among male fisherfolk living with HIV/AIDS in Uganda.
    PLoS One. 2019;14:e0216892.
    PubMed     Abstract available

  120. BAROCAS JA, So-Armah K, Cheng DM, Lioznov D, et al
    Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia.
    PLoS One. 2019;14:e0218852.
    PubMed     Abstract available

  121. GRAZIOLI VS, Gmel G, Rougemont-Bucking A, Baggio S, et al
    Attention deficit hyperactivity disorder and future alcohol outcomes: Examining the roles of coping and enhancement drinking motives among young men.
    PLoS One. 2019;14:e0218469.
    PubMed     Abstract available

  122. SILVER D, Macinko J, Giorgio M, Bae JY, et al
    Evaluating the relationship between binge drinking rates and a replicable measure of U.S. state alcohol policy environments.
    PLoS One. 2019;14:e0218718.
    PubMed     Abstract available

  123. LOPEZ V, Paladines B, Vaca S, Cacho R, et al
    Psychometric properties and factor structure of an Ecuadorian version of the Alcohol Use Disorders Identification Test (AUDIT) in college students.
    PLoS One. 2019;14:e0219618.
    PubMed     Abstract available

  124. LASOTA D, Goniewicz M, Kosson D, Ochal A, et al
    The effect of ethyl alcohol on the severity of injuries in fatal pedestrian victims of traffic crashes.
    PLoS One. 2019;14:e0221749.
    PubMed     Abstract available

  125. KNOX J, Schneider J, Greene E, Nicholson J, et al
    Using social network analysis to examine alcohol use among adults: A systematic review.
    PLoS One. 2019;14:e0221360.
    PubMed     Abstract available

  126. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0220507.
    PubMed     Abstract available

  127. KAUNE T, Hollenbach M, Keil B, Chen JM, et al
    Common variants in glyoxalase I do not increase chronic pancreatitis risk.
    PLoS One. 2019;14:e0222927.
    PubMed     Abstract available

  128. MARMET S, Studer J, Lemoine M, Grazioli VS, et al
    Reconsidering the associations between self-reported alcohol use disorder and mental health problems in the light of co-occurring addictions in young Swiss men.
    PLoS One. 2019;14:e0222806.
    PubMed     Abstract available

  129. KNERICH V, Jones AA, Seyedin S, Siu C, et al
    Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada.
    PLoS One. 2019;14:e0222611.
    PubMed     Abstract available

  130. ZUCKERMAN AD, Douglas A, Whelchel K, Choi L, et al
    Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
    PLoS One. 2019;14:e0225434.
    PubMed     Abstract available

  131. CALLING S, Ohlsson H, Sundquist J, Sundquist K, et al
    Socioeconomic status and alcohol use disorders across the lifespan: A co-relative control study.
    PLoS One. 2019;14:e0224127.
    PubMed     Abstract available

  132. AFSHAR M, Joyce C, Dligach D, Sharma B, et al
    Subtypes in patients with opioid misuse: A prognostic enrichment strategy using electronic health record data in hospitalized patients.
    PLoS One. 2019;14:e0219717.
    PubMed     Abstract available

  133. JIMENEZ VM JR, Settles EW, Currie BJ, Keim PS, et al
    Persistence of Burkholderia thailandensis E264 in lung tissue after a single binge alcohol episode.
    PLoS One. 2019;14:e0218147.
    PubMed     Abstract available

  134. FANTILLI AC, Trinks J, Marciano S, Zarate F, et al
    Unexpected high seroprevalence of hepatitis E virus in patients with alcohol-related cirrhosis.
    PLoS One. 2019;14:e0224404.
    PubMed     Abstract available

  135. GOLDSTICK JE, Walton MA, Bohnert ASB, Heinze JE, et al
    Predictors of alcohol use transitions among drug-using youth presenting to an urban emergency department.
    PLoS One. 2019;14:e0227140.
    PubMed     Abstract available

  136. VERHEIJ C, Rood PPM, Deelstra CK, Levendag MLL, et al
    Emergency Department visits due to intoxications in a Dutch university hospital: Occurrence, characteristics and health care costs.
    PLoS One. 2019;14:e0226029.
    PubMed     Abstract available

    January 2018
  137. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0191026.
    PubMed     Abstract available

  138. MAROT A, Dubois M, Trepo E, Moreno C, et al
    Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
    PLoS One. 2018;13:e0190823.
    PubMed     Abstract available

  139. ZAHR NM
    Peripheral TNFalpha elevations in abstinent alcoholics are associated with hepatitis C infection.
    PLoS One. 2018;13:e0191586.
    PubMed     Abstract available

  140. BAYERL C, Lorbeer R, Heier M, Meisinger C, et al
    Alcohol consumption, but not smoking is associated with higher MR-derived liver fat in an asymptomatic study population.
    PLoS One. 2018;13:e0192448.
    PubMed     Abstract available

  141. HUGHES E, Hopkins LJ, Parker R
    Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0192393.
    PubMed     Abstract available

  142. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0193138.
    PubMed     Abstract available

  143. BEATON LE, Azma S, Marinkovic K
    When the brain changes its mind: Oscillatory dynamics of conflict processing and response switching in a flanker task during alcohol challenge.
    PLoS One. 2018;13:e0191200.
    PubMed     Abstract available

  144. CHRISTENSEN CU, Glavind E, Thomsen KL, Kim YO, et al
    Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0192728.
    PubMed     Abstract available

  145. ALEXANDER KS, Zakai NA, Lidofsky SD, Callas PW, et al
    Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    PLoS One. 2018;13:e0194153.
    PubMed     Abstract available

  146. SIDORCHUK A, Goodman A, Koupil I
    Social class, social mobility and alcohol-related disorders in Swedish men and women: A study of four generations.
    PLoS One. 2018;13:e0191855.
    PubMed     Abstract available

  147. CURTIS B, Giorgi S, Buffone AEK, Ungar LH, et al
    Can Twitter be used to predict county excessive alcohol consumption rates?
    PLoS One. 2018;13:e0194290.
    PubMed     Abstract available

  148. HUGHES E, Hopkins LJ, Parker R
    Correction: Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0195857.
    PubMed     Abstract available

  149. MAYHUGH RE, Rejeski WJ, Petrie MR, Laurienti PJ, et al
    Differing patterns of stress and craving across the day in moderate-heavy alcohol consumers during their typical drinking routine and an imposed period of alcohol abstinence.
    PLoS One. 2018;13:e0195063.
    PubMed     Abstract available

  150. IRWIN C, van Reenen M, Mason S, Mienie LJ, et al
    The 1H-NMR-based metabolite profile of acute alcohol consumption: A metabolomics intervention study.
    PLoS One. 2018;13:e0196850.
    PubMed     Abstract available

  151. WANG J, Fan Y, Dong Y, Ma M, et al
    Combining gray matter volume in the cuneus and the cuneus-prefrontal connectivity may predict early relapse in abstinent alcohol-dependent patients.
    PLoS One. 2018;13:e0196860.
    PubMed     Abstract available

  152. RAY MH, Hanlon E, McDannald MA
    Lateral orbitofrontal cortex partitions mechanisms for fear regulation and alcohol consumption.
    PLoS One. 2018;13:e0198043.
    PubMed     Abstract available

  153. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0198379.
    PubMed     Abstract available

  154. ILIC M, Grujicic Sipetic S, Ristic B, Ilic I, et al
    Myocardial infarction and alcohol consumption: A case-control study.
    PLoS One. 2018;13:e0198129.
    PubMed     Abstract available

  155. HAO L, Wang LS, Liu Y, Wang T, et al
    The different course of alcoholic and idiopathic chronic pancreatitis: A long-term study of 2,037 patients.
    PLoS One. 2018;13:e0198365.
    PubMed     Abstract available

  156. MEHTA R, Shaw G, Masschelin P, Felix S, et al
    Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    PLoS One. 2018;13:e0199294.
    PubMed     Abstract available

  157. CHANG PE, Goh GBB, Leow WQ, Shen L, et al
    Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0199166.
    PubMed     Abstract available

  158. BULTUM JA, Yigzaw N, Demeke W, Alemayehu M, et al
    Alcohol use disorder and associated factors among human immunodeficiency virus infected patients attending antiretroviral therapy clinic at Bishoftu General Hospital, Oromiya region, Ethiopia.
    PLoS One. 2018;13:e0189312.
    PubMed     Abstract available

  159. HWANG A, Shi C, Zhu E, Naaz F, et al
    Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    PLoS One. 2018;13:e0198937.
    PubMed     Abstract available

  160. IRVINE L, Crombie IK, Swanson V, Dimova ED, et al
    Design and feasibility testing of a novel group intervention for young women who binge drink in groups.
    PLoS One. 2018;13:e0193434.
    PubMed     Abstract available

  161. BHATT SP, Guleria R, Vikram NK, Nandhan SV, et al
    Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    PLoS One. 2018;13:e0199599.
    PubMed     Abstract available

  162. LUBEN R, Hayat S, Mulligan A, Lentjes M, et al
    Alcohol consumption and future hospital usage: The EPIC-Norfolk prospective population study.
    PLoS One. 2018;13:e0200747.
    PubMed     Abstract available

  163. BOWDEN B, John A, Trefan L, Morgan J, et al
    Risk of suicide following an alcohol-related emergency hospital admission: An electronic cohort study of 2.8 million people.
    PLoS One. 2018;13:e0194772.
    PubMed     Abstract available

  164. MUNOZ M, Ausin B, Santos-Olmo AB, Harter M, et al
    Alcohol use, abuse and dependence in an older European population: Results from the MentDis_ICF65+ study.
    PLoS One. 2018;13:e0196574.
    PubMed     Abstract available

  165. VICHITKUNAKORN P, Balthip K, Geater A, Assanangkornchai S, et al
    Comparisons between context-specific and beverage-specific quantity frequency instruments to assess alcohol consumption indices: Individual and sample level analysis.
    PLoS One. 2018;13:e0202756.
    PubMed     Abstract available

  166. SANTOS GM, Rowe C, Hern J, Walker JE, et al
    Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco.
    PLoS One. 2018;13:e0202170.
    PubMed     Abstract available

  167. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    PubMed     Abstract available

  168. BHATT SP, Guleria R, Vikram NK, Vivekanandhan S, et al
    Correction: Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    PLoS One. 2018;13:e0203182.
    PubMed     Abstract available

  169. GUMMESSON A, Stromberg U, Schmidt C, Kullberg J, et al
    Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    PLoS One. 2018;13:e0202666.
    PubMed     Abstract available

  170. DEGUCHI Y, Iwasaki S, Kanchika M, Nitta T, et al
    Gender differences in the relationships between perceived individual-level occupational stress and hazardous alcohol consumption among Japanese teachers: A cross-sectional study.
    PLoS One. 2018;13:e0204248.
    PubMed     Abstract available

  171. WEGERMANN K, Henao R, Diehl AM, Murphy SK, et al
    Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLoS One. 2018;13:e0204308.
    PubMed     Abstract available

  172. WARNER DR, Liu H, Ghosh Dastidar S, Warner JB, et al
    Ethanol and unsaturated dietary fat induce unique patterns of hepatic omega-6 and omega-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
    PLoS One. 2018;13:e0204119.
    PubMed     Abstract available

  173. ARAYA D, Paraje G
    The impact of prices on alcoholic beverage consumption in Chile.
    PLoS One. 2018;13:e0205932.
    PubMed     Abstract available

  174. ADDO J, Cook S, Galbete C, Agyemang C, et al
    Differences in alcohol consumption and drinking patterns in Ghanaians in Europe and Africa: The RODAM Study.
    PLoS One. 2018;13:e0206286.
    PubMed     Abstract available

  175. PETTINELLI P, Arendt BM, Teterina A, McGilvray I, et al
    Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0205747.
    PubMed     Abstract available

  176. LEE J, Yoon K, Ryu S, Chang Y, et al
    Correction: High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2018;13:e0206834.
    PubMed     Abstract available

  177. DEGROAT AR, Fleming CK, Dunlay SM, Hagood KL, et al
    The sex specific effect of alcohol consumption on circulating levels of CTRP3.
    PLoS One. 2018;13:e0207011.
    PubMed     Abstract available

  178. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Abstract available

  179. HORMENU T, Hagan Jnr JE, Schack T
    Predictors of alcohol consumption among in-school adolescents in the Central Region of Ghana: A baseline information for developing cognitive-behavioural interventions.
    PLoS One. 2018;13:e0207093.
    PubMed     Abstract available

  180. JIMENEZ V JR, Moreno R, Settles E, Currie BJ, et al
    A mouse model of binge alcohol consumption and Burkholderia infection.
    PLoS One. 2018;13:e0208061.
    PubMed     Abstract available

  181. GUO Y, Hu H, Liu Y, Leng Y, et al
    Gender differences in the relationship between alcohol consumption and insomnia in the northern Chinese population.
    PLoS One. 2018;13:e0207392.
    PubMed     Abstract available

  182. DAHER S, Lev Cohen N, Massarwa M, Mahamid M, et al
    Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0207479.
    PubMed     Abstract available

  183. YANG JC, Roman-Urrestarazu A, Brayne C
    Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States.
    PLoS One. 2018;13:e0199741.
    PubMed     Abstract available

  184. SHANG C, Wang X, Chaloupka FJ
    The association between excise tax structures and the price variability of alcoholic beverages in the United States.
    PLoS One. 2018;13:e0208509.
    PubMed     Abstract available

  185. KNIBB G, Roberts CA, Robinson E, Rose A, et al
    The effect of beliefs about alcohol's acute effects on alcohol priming and alcohol-induced impairments of inhibitory control.
    PLoS One. 2018;13:e0201042.
    PubMed     Abstract available

  186. RANAWEERA S, Amarasinghe H, Chandraratne N, Thavorncharoensap M, et al
    Economic costs of alcohol use in Sri Lanka.
    PLoS One. 2018;13:e0198640.
    PubMed     Abstract available

  187. MAYHUGH RE, Laurienti PJ, Fanning J, Gauvin L, et al
    Cardiac vagal dysfunction moderates patterns of craving across the day in moderate to heavy consumers of alcohol.
    PLoS One. 2018;13:e0200424.
    PubMed     Abstract available

  188. MURALIDHARAN P, Sarmah S, Marrs JA
    Retinal Wnt signaling defect in a zebrafish fetal alcohol spectrum disorder model.
    PLoS One. 2018;13:e0201659.
    PubMed     Abstract available

  189. FRYE CCJ, Rung JM, Nall RW, Galizio A, et al
    Continuous nicotine exposure does not affect resurgence of alcohol seeking in rats.
    PLoS One. 2018;13:e0202230.
    PubMed     Abstract available

  190. JARMAN SK, Haney AM, Valdez GR
    Kappa opioid regulation of depressive-like behavior during acute withdrawal and protracted abstinence from ethanol.
    PLoS One. 2018;13:e0205016.
    PubMed     Abstract available

  191. JACQUET E, Robert S, Chauvin P, Menvielle G, et al
    Social inequalities in health and mental health in France. The results of a 2010 population-based survey in Paris Metropolitan Area.
    PLoS One. 2018;13:e0203676.
    PubMed     Abstract available

  192. PARK S, Kim MS
    An event-related potential study of spatial working memory in binge drinking college students.
    PLoS One. 2018;13:e0203696.
    PubMed     Abstract available

  193. FROST H, Campbell P, Maxwell M, O'Carroll RE, et al
    Effectiveness of Motivational Interviewing on adult behaviour change in health and social care settings: A systematic review of reviews.
    PLoS One. 2018;13:e0204890.
    PubMed     Abstract available

  194. PAN CS, Ju TR, Lee CC, Chen YP, et al
    Alcohol use disorder tied to development of chronic kidney disease: A nationwide database analysis.
    PLoS One. 2018;13:e0203410.
    PubMed     Abstract available

  195. VETRENO RP, Crews FT
    Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin.
    PLoS One. 2018;13:e0204500.
    PubMed     Abstract available

    January 2017
  196. SEIDEMANN T, Spies C, Morgenstern R, Wernecke KD, et al
    Influence of Volatile Anesthesia on the Release of Glutamate and other Amino Acids in the Nucleus Accumbens in a Rat Model of Alcohol Withdrawal: A Pilot Study.
    PLoS One. 2017;12:e0169017.
    PubMed     Abstract available

  197. SAKAKIBARA A, Sakakibara S, Kusumoto J, Takeda D, et al
    Upregulated Expression of Transient Receptor Potential Cation Channel Subfamily V Receptors in Mucosae of Patients with Oral Squamous Cell Carcinoma and Patients with a History of Alcohol Consumption or Smoking.
    PLoS One. 2017;12:e0169723.
    PubMed     Abstract available

  198. MULDER P, van den Hoek AM, Kleemann R
    The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
    PLoS One. 2017;12:e0169740.
    PubMed     Abstract available

  199. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    PubMed     Abstract available

  200. BONIFACE S, Scholes S, Shelton N, Connor J, et al
    Assessment of Non-Response Bias in Estimates of Alcohol Consumption: Applying the Continuum of Resistance Model in a General Population Survey in England.
    PLoS One. 2017;12:e0170892.
    PubMed     Abstract available

  201. HUANG CC, Kuo SC, Yeh YW, Chen CY, et al
    The SLC6A3 gene possibly affects susceptibility to late-onset alcohol dependence but not specific personality traits in a Han Chinese population.
    PLoS One. 2017;12:e0171170.
    PubMed     Abstract available

  202. KIWANUKA N, Ssetaala A, Ssekandi I, Nalutaaya A, et al
    Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda.
    PLoS One. 2017;12:e0171200.
    PubMed     Abstract available

  203. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    PubMed     Abstract available

  204. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    PubMed     Abstract available

  205. ROTEVATN TA, Boggild H, Olesen CR, Torp-Pedersen C, et al
    Alcohol consumption and the risk of postoperative mortality and morbidity after primary hip or knee arthroplasty - A register-based cohort study.
    PLoS One. 2017;12:e0173083.
    PubMed     Abstract available

  206. THOMPSON A, Ashcroft DM, Owens L, van Staa TP, et al
    Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.
    PLoS One. 2017;12:e0173272.
    PubMed     Abstract available

  207. THOMPSON A, Wright AK, Ashcroft DM, van Staa TP, et al
    Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink.
    PLoS One. 2017;12:e0174818.
    PubMed     Abstract available

  208. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0174544.
    PubMed     Abstract available

  209. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Abstract available

  210. HONG JW, Noh JH, Kim DJ
    The prevalence of and factors associated with high-risk alcohol consumption in Korean adults: The 2009-2011 Korea National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0175299.
    PubMed     Abstract available

  211. TAKAHASHI A, Kono S, Wada A, Oshima S, et al
    Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.
    PLoS One. 2017;12:e0174169.
    PubMed     Abstract available

  212. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    PubMed     Abstract available

  213. YEN YH, Chen JB, Cheng BC, Chen JF, et al
    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
    PLoS One. 2017;12:e0176027.
    PubMed     Abstract available

  214. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    PubMed     Abstract available

  215. ADEJUMO AC, Alliu S, Ajayi TO, Adejumo KL, et al
    Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
    PLoS One. 2017;12:e0176416.
    PubMed     Abstract available

  216. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Abstract available

  217. REHAN W, Antfolk J, Johansson A, Jern P, et al
    Experiences of severe childhood maltreatment, depression, anxiety and alcohol abuse among adults in Finland.
    PLoS One. 2017;12:e0177252.
    PubMed     Abstract available

  218. BERTOGLIA MP, Gormaz JG, Libuy M, Sanhueza D, et al
    The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010.
    PLoS One. 2017;12:e0178092.
    PubMed     Abstract available

  219. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0179070.
    PubMed     Abstract available

  220. NAKADE Y, Sakamoto K, Yamauchi T, Inoue T, et al
    Conophylline inhibits non-alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0178436.
    PubMed     Abstract available

  221. WAY MJ, Ali MA, McQuillin A, Morgan MY, et al
    Genetic variants in ALDH1B1 and alcohol dependence risk in a British and Irish population: A bioinformatic and genetic study.
    PLoS One. 2017;12:e0177009.
    PubMed     Abstract available

  222. Correction: Experiences of severe childhood maltreatment, depression, anxiety and alcohol abuse among adults in Finland.
    PLoS One. 2017;12:e0180316.
    PubMed     Abstract available

  223. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    PubMed     Abstract available

  224. PEREIRA ENGDS, Silvares RR, Flores EEI, Rodrigues KL, et al
    Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0179654.
    PubMed     Abstract available

  225. WANDERA B, Tumwesigye NM, Nankabirwa JI, Kambugu AD, et al
    Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
    PLoS One. 2017;12:e0180015.
    PubMed     Abstract available

  226. YEN CH, Wang KT, Lee PY, Liu CC, et al
    Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians.
    PLoS One. 2017;12:e0179898.
    PubMed     Abstract available

  227. KANAMORI H, Nakade Y, Yamauchi T, Sakamoto K, et al
    Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2017;12:e0180475.
    PubMed     Abstract available

  228. TEMBO C, Burns S, Kalembo F
    The association between levels of alcohol consumption and mental health problems and academic performance among young university students.
    PLoS One. 2017;12:e0178142.
    PubMed     Abstract available

  229. KIM J, Lee DY, Park SE, Park CY, et al
    Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    PLoS One. 2017;12:e0180118.
    PubMed     Abstract available

  230. YU J, Yang X, Luo Y, Yang X, et al
    Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
    PLoS One. 2017;12:e0180218.
    PubMed     Abstract available

  231. SCHOEMAKER MH, Kleemann R, Morrison MC, Verheij J, et al
    A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    PLoS One. 2017;12:e0180648.
    PubMed     Abstract available

  232. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    PubMed     Abstract available

  233. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Abstract available

  234. PETIT G, Luminet O, Cordovil de Sousa Uva M, Zorbas A, et al
    Differential spontaneous recovery across cognitive abilities during detoxification period in alcohol-dependence.
    PLoS One. 2017;12:e0176638.
    PubMed     Abstract available

  235. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Abstract available

  236. HOU W, Gupta S, Beauchamp MC, Yuan L, et al
    Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    PLoS One. 2017;12:e0182995.
    PubMed     Abstract available

  237. MUENCH F, van Stolk-Cooke K, Kuerbis A, Stadler G, et al
    A Randomized Controlled Pilot Trial of Different Mobile Messaging Interventions for Problem Drinking Compared to Weekly Drink Tracking.
    PLoS One. 2017;12:e0167900.
    PubMed     Abstract available

  238. MARTINO FP, Miller PG, Coomber K, Hancock L, et al
    Analysis of Alcohol Industry Submissions against Marketing Regulation.
    PLoS One. 2017;12:e0170366.
    PubMed     Abstract available

  239. WU CK, Liang CM, Hsu CN, Hung TH, et al
    The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    PLoS One. 2017;12:e0169884.
    PubMed     Abstract available

  240. ADAN A, Capella MD, Prat G, Forero DA, et al
    Executive Functioning in Men with Schizophrenia and Substance Use Disorders. Influence of Lifetime Suicide Attempts.
    PLoS One. 2017;12:e0169943.
    PubMed     Abstract available

  241. RISHI P, Arora S, Kaur UJ, Chopra K, et al
    Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
    PLoS One. 2017;12:e0168459.
    PubMed     Abstract available

  242. MA Z, Zhang Y, Li Q, Xu M, et al
    Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production.
    PLoS One. 2017;12:e0183426.
    PubMed     Abstract available

  243. HERMOSILLA S, You P, Aifah A, Abildayev T, et al
    Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.
    PLoS One. 2017;12:e0172942.
    PubMed     Abstract available

  244. CHO YE, Im EJ, Moon PG, Mezey E, et al
    Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    PLoS One. 2017;12:e0172463.
    PubMed     Abstract available

  245. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    PubMed     Abstract available

  246. HOMMA Y, Yamauchi S, Mizobe M, Nakashima Y, et al
    Emergency department outpatient treatment of alcohol-intoxicated bicyclists increases the cost of medical care in Japan.
    PLoS One. 2017;12:e0174408.
    PubMed     Abstract available

  247. CARBIA C, Cadaveira F, Caamano-Isorna F, Rodriguez-Holguin S, et al
    Binge drinking during adolescence and young adulthood is associated with deficits in verbal episodic memory.
    PLoS One. 2017;12:e0171393.
    PubMed     Abstract available

  248. LEE JY, Shin DW, Oh JW, Kim W, et al
    Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.
    PLoS One. 2017;12:e0182708.
    PubMed     Abstract available

  249. KJAERGAARD M, Thiele M, Jansen C, Staehr Madsen B, et al
    High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.
    PLoS One. 2017;12:e0173992.
    PubMed     Abstract available

  250. NIER A, Engstler AJ, Maier IB, Bergheim I, et al
    Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    PLoS One. 2017;12:e0183282.
    PubMed     Abstract available

  251. LAMBERTI M, Napolitano F, Napolitano P, Arnese A, et al
    Prevalence of alcohol use disorders among under- and post-graduate healthcare students in Italy.
    PLoS One. 2017;12:e0175719.
    PubMed     Abstract available

  252. HERRADOR Z, Fernandez-Martinez A, Gomez-Barroso D, Leon I, et al
    Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records.
    PLoS One. 2017;12:e0174745.
    PubMed     Abstract available

  253. MARTINS JG, de Paiva HN, Paiva PCP, Ferreira RC, et al
    New evidence about the "dark side" of social cohesion in promoting binge drinking among adolescents.
    PLoS One. 2017;12:e0178652.
    PubMed     Abstract available

  254. DUC C, Pradal M, Sanchez I, Noble J, et al
    A set of nutrient limitations trigger yeast cell death in a nitrogen-dependent manner during wine alcoholic fermentation.
    PLoS One. 2017;12:e0184838.
    PubMed     Abstract available

  255. LI P, Becker JB, Heitzeg MM, McClellan ML, et al
    Gender differences in the transmission of risk for antisocial behavior problems across generations.
    PLoS One. 2017;12:e0177288.
    PubMed     Abstract available

  256. MULLER J, Ganeshamoorthy S, Myers J
    Risk factors associated with posttraumatic stress disorder in US veterans: A cohort study.
    PLoS One. 2017;12:e0181647.
    PubMed     Abstract available

  257. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Abstract available

  258. CAMARGO MORENO M, Mooney SM, Middleton FA
    Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder.
    PLoS One. 2017;12:e0180873.
    PubMed     Abstract available

  259. WLODARCZYK O, Schwarze M, Rumpf HJ, Metzner F, et al
    Protective mental health factors in children of parents with alcohol and drug use disorders: A systematic review.
    PLoS One. 2017;12:e0179140.
    PubMed     Abstract available

  260. DING L, Wo L, Du Z, Tang L, et al
    Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARalpha activation and subsequent 4-HNE degradation.
    PLoS One. 2017;12:e0186357.
    PubMed     Abstract available

  261. DIXIT S, Alonso A, Vittinghoff E, Soliman E, et al
    Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study.
    PLoS One. 2017;12:e0185228.
    PubMed     Abstract available

  262. AAS RW, Haveraaen L, Sagvaag H, Thorrisen MM, et al
    The influence of alcohol consumption on sickness presenteeism and impaired daily activities. The WIRUS screening study.
    PLoS One. 2017;12:e0186503.
    PubMed     Abstract available

  263. WILLMORE J, Marko TL, Taing D, Sampasa-Kanyinga H, et al
    The burden of alcohol-related morbidity and mortality in Ottawa, Canada.
    PLoS One. 2017;12:e0185457.
    PubMed     Abstract available

  264. MEYER JM, Percheski C
    Health behaviors and union dissolution among parents of young children: Differences by marital status.
    PLoS One. 2017;12:e0182628.
    PubMed     Abstract available

  265. AUGUET T, Aragones G, Berlanga A, Martinez S, et al
    Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0187065.
    PubMed     Abstract available

  266. RASCH S, Notzel B, Phillip V, Lahmer T, et al
    Management of pancreatic pseudocysts-A retrospective analysis.
    PLoS One. 2017;12:e0184374.
    PubMed     Abstract available

  267. MAROT A, Henrion J, Knebel JF, Moreno C, et al
    Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    PLoS One. 2017;12:e0186715.
    PubMed     Abstract available

  268. FRIEDRICH-RUST M, Schoelzel F, Maier S, Seeger F, et al
    Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    PLoS One. 2017;12:e0186720.
    PubMed     Abstract available

  269. KIM S, Chang Y, Sung E, Kim CH, et al
    Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.
    PLoS One. 2017;12:e0184506.
    PubMed     Abstract available

  270. ROESSLER KK, Bilberg R, Sogaard Nielsen A, Jensen K, et al
    Exercise as adjunctive treatment for alcohol use disorder: A randomized controlled trial.
    PLoS One. 2017;12:e0186076.
    PubMed     Abstract available

  271. CHIAFFARINO F, Cipriani S, Ricci E, La Vecchia C, et al
    Alcohol consumption and risk of uterine myoma: A systematic review and meta analysis.
    PLoS One. 2017;12:e0188355.
    PubMed     Abstract available

  272. GARCIA-MARCHENA N, Silva-Pena D, Martin-Velasco AI, Villanua MA, et al
    Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.
    PLoS One. 2017;12:e0187634.
    PubMed     Abstract available

  273. ALAZAWI W, Bernabe E, Tai D, Janicki T, et al
    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0185902.
    PubMed     Abstract available

  274. BACIU C, Pasini E, Angeli M, Schwenger K, et al
    Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0189223.
    PubMed     Abstract available

  275. NIEMELA O, Niemela M, Bloigu R, Aalto M, et al
    Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?
    PLoS One. 2017;12:e0188574.
    PubMed     Abstract available

  276. MILOYAN B, Bulley A, Brilot B, Suddendorf T, et al
    The association of Social Anxiety Disorder, Alcohol Use Disorder and reproduction: Results from four nationally representative samples of adults in the USA.
    PLoS One. 2017;12:e0188436.
    PubMed     Abstract available

  277. TAYLOR AW, Bewick BM, Makanjuola AB, Qian L, et al
    Context and culture associated with alcohol use amongst youth in major urban cities: A cross-country population based survey.
    PLoS One. 2017;12:e0187812.
    PubMed     Abstract available

  278. YOO W, Gjuka D, Stevenson HL, Song X, et al
    Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
    PLoS One. 2017;12:e0189965.
    PubMed     Abstract available

  279. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    PubMed     Abstract available

  280. SANDAHL TD, Stoy SH, Laursen TL, Rodgaard-Hansen S, et al
    The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    PLoS One. 2017;12:e0189345.
    PubMed     Abstract available

  281. PAN JH, Lim Y, Kim JH, Heo W, et al
    Root bark of Ulmus davidiana var. japonica restrains acute alcohol-induced hepatic steatosis onset in mice by inhibiting ROS accumulation.
    PLoS One. 2017;12:e0188381.
    PubMed     Abstract available

  282. DIXIT S, Alonso A, Vittinghoff E, Soliman EZ, et al
    Correction: Past alcohol consumption and incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study.
    PLoS One. 2017;12:e0190329.
    PubMed     Abstract available

  283. DURBEEJ N, Elgan TH, Jalling C, Gripenberg J, et al
    Alcohol intoxication at Swedish football matches: A study using biological sampling to assess blood alcohol concentration levels among spectators.
    PLoS One. 2017;12:e0188284.
    PubMed     Abstract available

  284. CICHOWITZ C, Maraba N, Hamilton R, Charalambous S, et al
    Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa.
    PLoS One. 2017;12:e0189820.
    PubMed     Abstract available

    January 2016
  285. YE Q, Qian BX, Yin WL, Wang FM, et al
    Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.
    PLoS One. 2016;11:e0163423.
    PubMed     Abstract available

  286. SONG DS, Chang UI, Choi S, Jung YD, et al
    Heavy Alcohol Consumption with Alcoholic Liver Disease Accelerates Sarcopenia in Elderly Korean Males: The Korean National Health and Nutrition Examination Survey 2008-2010.
    PLoS One. 2016;11:e0163222.
    PubMed     Abstract available

  287. VIEIRA BA, Luft VC, Schmidt MI, Chambless LE, et al
    Timing and Type of Alcohol Consumption and the Metabolic Syndrome - ELSA-Brasil.
    PLoS One. 2016;11:e0163044.
    PubMed     Abstract available

  288. HE XX, Wu XL, Chen RP, Chen C, et al
    Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0162368.
    PubMed     Abstract available

  289. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    PubMed     Abstract available

  290. SHIMIZU J, Okazaki S, Nagoya S, Takahashi N, et al
    Susceptibility of Males, but Not Females to Developing Femoral Head Osteonecrosis in Response to Alcohol Consumption.
    PLoS One. 2016;11:e0165490.
    PubMed     Abstract available

  291. BOUTTELL J, Lewsey J, Geue C, Antony G, et al
    The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.
    PLoS One. 2016;11:e0162980.
    PubMed     Abstract available

  292. MOURE-RODRIGUEZ L, Pineiro M, Corral Varela M, Rodriguez-Holguin S, et al
    Identifying Predictors and Prevalence of Alcohol Consumption among University Students: Nine Years of Follow-Up.
    PLoS One. 2016;11:e0165514.
    PubMed     Abstract available

  293. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Abstract available

  294. HSU TY, Shih HM, Wang YC, Lin LC, et al
    Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study.
    PLoS One. 2016;11:e0165411.
    PubMed     Abstract available

  295. STRATE LL, Singh P, Boylan MR, Piawah S, et al
    A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men.
    PLoS One. 2016;11:e0165278.
    PubMed     Abstract available

  296. ZHOU Z, Song K, Qiu J, Wang Y, et al
    Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
    PLoS One. 2016;11:e0166072.
    PubMed     Abstract available

  297. LEE M, Kim W, Choi Y, Kim S, et al
    Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis.
    PLoS One. 2016;11:e0167184.
    PubMed     Abstract available

  298. TAYLOR M, Simpkin AJ, Haycock PC, Dudbridge F, et al
    Exploration of a Polygenic Risk Score for Alcohol Consumption: A Longitudinal Analysis from the ALSPAC Cohort.
    PLoS One. 2016;11:e0167360.
    PubMed     Abstract available

  299. JEURISSEN ML, Walenbergh SM, Houben T, Hendrikx T, et al
    Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    PLoS One. 2016;11:e0167199.
    PubMed     Abstract available

  300. LECUBE A, Valladares S, Lopez-Cano C, Gutierrez L, et al
    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    PLoS One. 2016;11:e0166741.
    PubMed     Abstract available

  301. SHANAKI M, Fadaei R, Moradi N, Emamgholipour S, et al
    The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
    PLoS One. 2016;11:e0168082.
    PubMed     Abstract available

  302. MCMAHAN RH, Porsche CE, Edwards MG, Rosen HR, et al
    Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0168301.
    PubMed     Abstract available

  303. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Abstract available

  304. SHEARN CT, Orlicky DJ, McCullough RL, Jiang H, et al
    Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.
    PLoS One. 2016;11:e0154152.
    PubMed     Abstract available

  305. FAIRBAIRN NS, Walley AY, Cheng DM, Quinn E, et al
    Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia.
    PLoS One. 2016;11:e0166539.
    PubMed     Abstract available

  306. AURPIBUL L, Tangmunkongvorakul A, Musumari PM, Srithanaviboonchai K, et al
    Patterns of Sexual Behavior in Lowland Thai Youth and Ethnic Minorities Attending High School in Rural Chiang Mai, Thailand.
    PLoS One. 2016;11:e0165866.
    PubMed     Abstract available

  307. IKEDA ML, Barcellos NT, Alencastro PR, Wolff FH, et al
    Alcohol Drinking Pattern: A Comparison between HIV-Infected Patients and Individuals from the General Population.
    PLoS One. 2016;11:e0158535.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.